ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
8 months ago
linkedin.com
The News That Could Stoke BridgeBio, Up 80% This Year
The News That Could Stoke BridgeBio, Up 80% This Year
7 months ago
investors.com
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman
2:09
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman
23.4K views6 months ago
FacebookMorgan Freeman
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Acoramidis: A Potential Breakthrough Treatment for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Cardiology
Jul 18, 2023
labroots.com
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
6 months ago
finanznachrichten.de
Impact of Attruby on serum TTR levels
Impact of Attruby on serum TTR levels
5 months ago
linkedin.com
Please see Important Safety Information at Attruby.com/#ISI for Attruby™ (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. #SponsoredbyAttruby It’s an honor to work with the BridgeBio team to raise awareness for ATTR-cardiac amyloidosis (ATTR-CM) and the help Attruby can give to those with the disease. Visit Attruby.com to learn more about the impact of this treatment. For US audiences only. | Morgan Freeman
0:59
Please see Important Safety Information at Attruby.com/#ISI for Attruby™ (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. #SponsoredbyAttruby It’s an honor to work with the BridgeBio team to raise awareness for ATTR-cardiac amyloidosis (ATTR-CM) and the help Attruby can give to those with the disease. Visit Attruby.com to learn more about the impact of this treatment. For US audiences only. | Morgan Freeman
57.5K views11 months ago
FacebookMorgan Freeman
0:40
New Breakthrough in Heart Failure Treatment: Acoramidis for ATTR-CM
1.6K viewsDec 5, 2024
YouTubeMUSC Health
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Mar 31, 2025
finanznachrichten.de
BridgeBio Pharma reports Attruby product revenue $146 mln in Q4
3 months ago
marketscreener.com
BridgeBio Pharma Announces Long-Term Efficacy And Safety Data For Acoramidis In Patients With ATTR-CM
1 month ago
marketscreener.com
5:03
Support for Your Patients Throughout the Attruby® (acoramidis) Treatment Journey
40 views1 month ago
YouTubeAttruby® (acoramidis)
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endpoint At Month 12
Dec 27, 2021
nasdaq.com
3:53
Recognizing Early Indicators of ATTR-CM
175 viewsDec 11, 2024
YouTubeAttruby® (acoramidis)
Attruby TV Spot, 'A Diagnosis Doesn't Define You' Featuring Morgan Freeman
Apr 1, 2025
iSpot.tv
2:01
Morgan Freeman discusses Attruby® (acoramidis)
1 month ago
YouTubeAttruby® (acoramidis)
Morgan Freeman on Instagram: "Please see Important Safety Information, Full Prescribing Information, and Patient Information at @attruby_pi. Morgan Freeman does not live with ATTR-CM. #SponsoredbyAttruby It’s an honor to work with the BridgeBio team to raise awareness for ATTR-cardiac amyloidosis (ATTR-CM) and the help Attruby can give to those with the disease. Visit Attruby.com to learn more about the impact of this treatment. For US audiences only."
95.3K views11 months ago
Instagrammorganfreeman
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones
Jan 13, 2025
finanznachrichten.de
3:29
Lawrence Livermore National Lab on Instagram: "In a milestone for supercomputing-aided drug design, @Livermore_lab and BridgeBio Oncology Therapeutics announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. Explore how this pioneering effort could accelerate the development of new treatments, offering renewed hope for patients worldwide. Learn more at the link in our bio."
5.1K viewsJun 6, 2024
Instagramlivermore_lab
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
2 months ago
llnl.gov
Early Diagnosis of Transthyretin Amyloid Cardiomyopathy
8 months ago
medscape.com
4:51
ATTRUBY - FDA NDA approval - 2024-11-22
221 viewsDec 11, 2024
YouTubeInside Drug Discovery
1:01
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. #morganfreeman #learn
112 views6 months ago
YouTubeMorgan Freeman
BridgeBio's Most 'Hotly Debated' Drug Scores Big In Phase 3
2 months ago
investors.com
We’re honored to be recognized at this year’s Med Ad News Manny Awards with four nominations! Our work on Attruby’s “Golden Years” campaign with BridgeBio has been nominated for Best Consumer Print… | GSW, powered by Syneos Health
1 month ago
linkedin.com
19:42
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，2026年股價上看多少？#BBIO #BridgeBio #美股分析 #生技股 #罕見疾病 #Attruby
23 views2 months ago
YouTube來聽美股吧
7:33
罕見疾病新星爆發！BridgeBio (BBIO) 三大新藥報捷，單挑輝瑞巨頭，2026年股價上看多少？#BBIO #BridgeBio #美股分析 #生技股 #罕見疾病 #Attruby
39 views2 months ago
YouTube來聽美股吧
BridgeBio LLC
Nov 30, 2017
biospace.com
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
144 views9 months ago
YouTubeMelissa Bime
1:52
How BridgeBio Transformed Compliance With Egnyte’s GxP Compliant Platform
124 viewsApr 30, 2025
YouTubeEgnyte
See more